Arkolith/Insider Trading/CALA/Form 4

Takeda Pharmaceutical Co Ltd

10% OwnerCalithera Biosciences, Inc. (CALA) · full profile →Form 4 · filed Jul 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2022Other(J)1.0M—$00
Jul 1, 2022Other(J)1.0M—$01.0M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001395064-22-000119) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML